Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros

Medicinas Complementárias
Métodos Terapéuticos y Terapias MTCI
País/Región como asunto
Tipo del documento
Intervalo de año de publicación
1.
Sci Rep ; 11(1): 2969, 2021 02 03.
Artículo en Inglés | MEDLINE | ID: mdl-33536564

RESUMEN

With the progression of acute cholecystitis, antimicrobial therapy becomes important for infection control. Current antibiotic recommendations were mostly based on reports of patients with acute cholangitis whose bile specimens were sampled from the biliary tract. However, as most infections of acute cholecystitis are limited to the gallbladder, direct sampling from the site increases the probability of identifying the causative pathogen. We investigated 321 positive bile cultures from 931 patients with acute cholecystitis who underwent laparoscopic cholecystectomy between January 2003 and December 2017. The frequency of enterococci declined (P = 0.041), whereas that of Enterobacteriales (P = 0.005), particularly Escherichia (P = 0.008), increased over time. The incidence of ciprofloxacin-resistant Enterobacteriales showed a significant increasing trend (P = 0.031). Vancomycin-resistant E.faecium, carbapenem-resistant Enterobacteriales, and extended-spectrum beta-lactamase-producing Enterobacteriales were recently observed. In grade I and II acute cholecystitis, there were no significant differences in perioperative outcomes in patients with and without early appropriate antimicrobial therapy. In conclusion, the changing incidence of frequently isolated microorganisms and their antibiotic resistance over time would be considered before selecting antibiotics for the treatment of acute cholecystitis. Surgery might be a crucial component of infection control in grade I and II acute cholecystitis.


Asunto(s)
Antibacterianos/uso terapéutico , Bilis/microbiología , Colecistitis Aguda/terapia , Colelitiasis/terapia , Vesícula Biliar/microbiología , Anciano , Antibacterianos/farmacología , Colecistectomía Laparoscópica , Colecistitis Aguda/microbiología , Colelitiasis/complicaciones , Colelitiasis/microbiología , Farmacorresistencia Bacteriana , Femenino , Humanos , Masculino , Pruebas de Sensibilidad Microbiana , Persona de Mediana Edad , Estudios Retrospectivos , Resultado del Tratamiento
2.
Surg Infect (Larchmt) ; 18(3): 345-349, 2017 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-28394748

RESUMEN

BACKGROUND: The aim of the study was to describe the microbiology and susceptibility patterns in acute cholecystitis by examining bile culture results from patients who underwent percutaneous cholecystostomy and examine concordance with empiric treatment. PATIENTS AND METHODS: A total of 124 patients with acute cholecystitis underwent percutaneous cholecystostomy between 2003 and 2012 at Emek Medical Center, Israel. Data on bile and blood culture results, isolate susceptibility, and clinical outcomes were retrieved from patient files. RESULTS: Bile cultures obtained from 116 patients were positive in 70 (60.3%) patients. Blood cultures obtained from 77 patients were positive in 23 (31.1%). Escherichia coli was the most common isolate in 28.6% of bile cultures and 43.5% of blood cultures. The concordance between empiric treatment coverage and culture isolate susceptibility was 67.6%. In most discordant cases, the isolates were Enterobacter spp. (40.9%) and Enterococcus spp. (31.8%). Overall, the in-hospital mortality rate was 7%: 2% in patients with concordant treatment compared with 14% in patients with discordant treatment (p = 0.09). Empiric antibiotic regimens were adequate in only two-thirds of patients. CONCLUSIONS: There might be a trend for poorer outcome in patients treated with inadequate antibiotic agents, emphasizing the importance of tailoring antibiotic treatment.


Asunto(s)
Antibacterianos/uso terapéutico , Bacterias/efectos de los fármacos , Bilis/microbiología , Colecistitis Aguda/microbiología , Adulto , Anciano , Anciano de 80 o más Años , Antibacterianos/farmacología , Bacterias/clasificación , Bacterias/aislamiento & purificación , Colecistitis Aguda/tratamiento farmacológico , Colecistitis Aguda/cirugía , Colecistostomía , Femenino , Humanos , Israel , Masculino , Pruebas de Sensibilidad Microbiana , Persona de Mediana Edad , Resultado del Tratamiento
3.
Rev. chil. pediatr ; 77(1): 48-51, feb. 2006. ilus
Artículo en Español | LILACS | ID: lil-469644

RESUMEN

Introducción: La colecistitis aguda es una patología muy infrecuente en el periodo neonatal. Objetivo: Presentar el caso de un recién nacido con una colecistitis aguda asociada a una sepsis por Staphylococcus aureus. Caso clínico: Recién nacido de término, de sexo femenino, de 23 días de vida, que presentó signos clínicos de septicemia, asociado a un abdomen agudo que requirió una laparotomía exploradora encontrándose una vesícula hidrópica e inflamada que requirió de una colecistectomía, la biopsia confirmó una colecistitis aguda. Conclusión: La colecistitis aguda neonatal es una patología muy infrecuente. Clínicamente se presenta como un abdomen agudo o una masa abdominal palpable. El diagnóstico se sospecha con la ecografía y se confirma por laparotomía.


Asunto(s)
Humanos , Femenino , Recién Nacido , Colecistitis Aguda/diagnóstico , Colecistitis Aguda/microbiología , Infecciones Estafilocócicas/complicaciones , Staphylococcus aureus , Sepsis/microbiología , Abdomen Agudo/microbiología , Evolución Clínica , Colecistitis Aguda/terapia , Resultado del Tratamiento
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA